The event, which was cancelled last year because of the Covid-19 pandemic, is the first opportunity for the profession to get back together after the past two turbulent years. To mark BEVA’s 60th Birthday, special celebrations are in the pipeline as well as the 13th International Equine Colic Symposium taking place during the event.
BEVA President Lucy Grieve said: "We are all so excited that BEVA Congress is back this year, albeit that it will be a little bit different. You can expect the same event we all know and love but with a few new measures in place to ensure we can all stay safe during these uncertain times. We are also offering a virtual option for those that can’t attend in person, so that no one misses out.”
Congress Committee co-chair Tim Barnett said: “My co-chair Ceri Sherlock and I have been working hard over the past few months to put together a programme that rivals anything we’ve had before. You can expect lectures, discussion and debates on a number of topics including learning from mistakes, working in teams, and a dedicated stream of nursing lectures.”
This year Lucy has selected teamwork as the theme for BEVA Congress 2021, in celebration of the Association’s 60th anniversary. She said: “In modern day veterinary medicine, no one person can satisfactorily deliver all that is required.
“Without a team approach, from vets, nurses, practice managers, farriers and paraprofessionals the potential to maximise the health and welfare of horses cannot be fulfilled.
"This year, we intend to celebrate 60 years of teamwork and how we can do far more to serve our patients as a harmonious team than if we work alone.”
Early bird tickets for BEVA Congress are available from 19th April until 16th August 2021. Tickets provide access to all three lecture halls and exhibition halls as well as the virtual congress hub. They also include a complimentary ticket to the 13th International Equine Colic Symposium.
Early bird BEVA member prices are £499 for vets and £187 for vet nurses for all 3 days (with concessions available for those in their first three years of graduation or on a lower salary). Virtual tickets are £99 for BEVA members.
BEVA has introduced a 'peace of mind' bookings policy to reassure those whose personal situation may change between booking their ticket and the event.
Full details of the BEVA Congress programme will be announced shortly. To find out more and to book your tickets visit http://www.bevacongress.org/
Having experienced the profession both as a clinician and as a director, Clive says he wanted to develop and integrate his skills to support fellow professionals. So, during lockdown, he embarked on a Master’s in Executive Coaching from Ashridge Hult Business School.
Clive said: "Studying for the Master’s was intellectually and emotionally tough. The emphasis was on psychology and relationships, working to the highest standards of ethical coaching practice. It has not only developed my coaching skills but also afforded me the opportunity to scrutinise the drivers and motivations behind my career choices and integrate them into a wider appreciation of life and my ‘self’. I am incredibly proud of this achievement and conscious of the privilege afforded me."
Clive's service typically involves six ninety-minute sessions during which he'll help you develop skills, behaviours and ways of behaving that will make you a better leader, particularly if you come from a clinical background where you'd be used to using very different skillset.
Clive, who is also a European Mentoring and Coaching Council Senior Practitioner, added: "In my practice as a coach, I am grateful for the opportunity to support others, whatever their life experiences, as they negotiate the challenges of being themselves, in the workplace, serving their communities.”
For more information, visit: www.trelliscoaching.co.uk
Canaural contains fusidic acid, framycetin and nystatin for their antibacterial and antifungal effects against the most common organisms associated with otitis externa.
Fusidic acid has skin penetrating properties and is active against staphylococci and streptococci1. Framycetin is active against Gram negative species. Dechra says the combination of the two provides an enhanced antibacterial effect on the most common bacterial cause of canine otitis2.
Nystatin is active against malassezia and prednisolone helps to provide anti-inflammatory and anti-pruritic action.
Dechra Brand Manager Carol Morgan said: “The reintroduction of Canaural to the veterinary treatment market means that once again veterinarians have this reliable and effective treatment available to tackle one of the most common canine complaints.
"Canaural is a tried and tested product and a recent study showed that fusidic acid is highly efficacious against both methicillin sensitive and methicillin resistant strains of Staphylococcus pseudintermedius3. Canaural remains as relevant today as it has ever been."
Canaural comes in 15 ml and 25 ml bottle sizes and is now available in veterinary wholesalers.
References
Elanco says Baycox Iron offers a time-saving flexible dosing treatment which complements the company’s existing piglet gut health portfolio.
Louise Radford, marketing manager at Elanco, said: "By treating piglets at two or three days old, it’s possible to allow enough exposure to the coccidiosis parasite to enable them to develop natural immunity, while preventing any damage to the gut caused by subclinical and clinical coccidiosis which leads to poor growth and low weaning weights.
"By combining treatments, it's possible to limit the number of times they are handled, which in turn reduces stress and enhances growth”.
Elanco also makes the Coliprotec vaccine against post weaning diarrhoea (PWD).
Louise added: “As farmers and vets prepare for the removal of zinc oxide as a treatment option next year, focusing on gut health throughout all stages of development has never been more crucial.
For more information, contact your Elanco pig team specialist or visit https://www.myelanco.co.uk/cpd/swine/hub.
Animalcare hopes that its ‘Make Senior Easier’ campaign will raise awareness of conditions that can go unnoticed or get dismissed by owners as a normal part of ageing, such as hyperthyroidism.
As part of the campaign, practices can request a free resource pack which includes:
Kirsty Cavill RVN said: ''In my role as a RVN and canine rehabilitation therapist, I often come across senior pets with underlying conditions which are adversely affecting their health but could be managed successfully through a multimodal approach and structured treatment plan.
"By adopting a proactive approach to senior pet care and by helping owners to understand how to best support their pets through this life stage, we will strengthen the bonds with our clients, to ensure the highest standard of care is afforded to all senior patients.''
James Beaumont, Brand Manager at Animalcare, added: "As life expectancy increases and numbers of senior pets continue to grow, veterinary care tailored to the needs of these animals has never been more relevant and it is also a huge business opportunity for practices. To help them capitalise on this opportunity, we have created our Make Senior Easier campaign and hope that the resources we have created will improve owner awareness and give practices the tools they need to achieve the best clinical outcomes for older pets and their owners.”
To request your free resource pack, visit: www.animalcare.co.uk/makesenioreasier.
For more information, contact your Animalcare Territory Manager or ring 01904 487687.
Zoetis says Librela (bedinvetmab) and Solensia (frunevetmab) work differently from NSAIDs, the current standard of care, by specifically targeting NGF, a key player in OA pain1.
As monoclonal antibodies, they are eliminated by the body in the same way as naturally occurring proteins, with minimal involvement of the liver or the kidney2.
John Innes, BVSc, PhD, MRCVS (Small Animal Orthopaedics), Chief Veterinary Officer and Referrals Director at CVS said: “The potential for anti-NGF therapy to control OA pain is an exciting new development, representing a new therapeutic class, an innovative tool for clinicians working to alleviate OA pain, and a new medicinal innovation.
"NGF is one of the key factors mediating pain, inducing the release of both proinflammatory mediators and more NGF contributing to a cycle of pain and inflammation. I welcome this innovative tool for clinicians working to alleviate OA pain.”
In a field study (three-month placebo-controlled, followed by six months continuation therapy), Librela administered as monthly injections demonstrated a reduction in osteoarthritis pain as compared to placebo-controlled dogs.
According to the company, the pain reduction was maintained throughout the six-month continuation study, demonstrating sustained efficacy of Librela for at least nine months.
Solensia administered as monthly injections during two multi-center, randomized, placebo-controlled, double-blind field studies that enrolled a total of 360 cats demonstrated that in both studies, ≥76% Solensia-treated cats were considered a treatment success by the owners and veterinary-assessed joint pain scores decreased by >50% in these cats by study end2.
Mike McFarland, DVM, Executive Vice President and Chief Medical Officer at Zoetis said: “Globally osteoarthritis (OA) pain impacts nearly 40% of cats and dogs suffering from the condition2,4.
"OA pain is under-diagnosed as pet owners often think signs of pain are related to ‘normal’ signs of ageing.
"The most common medications used to treat OA pain today are Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)1, While effective, current treatment choices can have limitations. Additionally, middle aged to senior pets may have other diseases that require multiple medications. Not all pets respond to NSAID therapy and some will not tolerate NSAIDs. This can lead to under-treatment today of OA pain.
“With Solensia for cats and Librela for dogs, veterinarians will now have access to once-monthly breakthrough solutions for the management of pain associated with osteoarthritis – offering a new alternative to veterinarians to improve the quality of life for pets and their owners.”
Librela (bedinvetmab) is launched today in the European Union, United Kingdom and Switzerland. Solensia (frunevetmab) will launch in Europe, United Kingdom and Switzerland in May.
Prevexxion RN is composed of a serotype-1 construct vaccine which Boehringer says offers a unique balance between safety and efficacy against the most virulent types of Marek’s disease virus strains.
Prevexxion RN+HVT+IBD is a solution combining Prevexxion RN and Vaxxitek HVT+IBD in one ampoule. It is designed to meet the needs of customers in long-life bird segments with protection from the hatchery.
Prevexxion RN vaccines are available in ampoules of 1000, 2000, and 4000 doses, frozen in liquid nitrogen.
Jerôme Baudon, Head of Poultry at Boehringer Ingelheim, said: “Our Prevexxion RN range provides value through innovation to Marek sensitive poultry producers looking for continuous live production productivity improvement and effective protection. Field and lab experiments conducted worldwide demonstrated its safety, efficacy and its strong, early, and long-lasting protection through the lifespan of the birds and against very virulent Marek’s disease challenge.
Prevexxion RN is the new golden standard for Marek's disease vaccination programs2”.
For more information, contact your Boehringer Ingelheim representative.
Reference
60 vets took part in the survey. 80% believed they had seen an increase in behavioural problems since lockdown. Over 60% reported an increase in the incidence of obesity and diarrhoea. Nearly 50% had seen an increase in urinary tract disorders and haemorrhagic gastroenteritis.
When asked which conditions had been harder to manage clinically since the start of the pandemic, the top seven conditions were:
Medicine specialist, Dr Stefanie Mitze (pictured right) said: “We conducted the survey to help us understand changes in disease incidence and the clinical challenges faced by our colleagues in first opinion practice over the last year.
"The fact that the incidence of disorders which can have a stress-related component, including behavioural problems, diarrhoea and urinary tract disease, were reported to have increased by a high proportion of respondents indicates that many pets may be experiencing heightened stress during the pandemic.”
Stefanie is now creating a series of free bitesize CPD videos to help manage these more challenging cases. She said: “We recognise the past year has been challenging, especially with complex staffing issues, reduced vet visits and restricted face-to-face communication with clients. For complex, chronic medical conditions, especially those which require frequent follow up, we wanted to support colleagues in providing the best care possible in the current circumstances. We hope these CPD sessions will provide practical tips to help deliver just that.
The CPD sessions are available at: https://www.hamiltonspecialists.vet
The new leaflet, ‘Separation anxiety as a result of the pandemic. What can you do?’, was written in collaboration with clinical animal behaviourist, Rosie Bescoby, and is aimed at dog owners whose pets are struggling to adjust to the ‘new normal’.
It includes an overview of separation anxiety, including the signs to look out for and how to tackle it, together with training tips to help adult dogs and preventative advice for puppies.
The leaflet also includes advice on the dog fear ladder, which demonstrates the different levels of fear a dog may exhibit resulting in more extreme reactions being displayed, and information on the Adaptil range of products which help support dogs throughout their lives.
The leaflet is available as both a printed and online version to enable vet practices to distribute it to their clients in a format of their choice. It is supported by a social media toolkit for vet practices consisting of posts, graphics and a video.
Abigail King, senior behaviour product manager at Ceva Animal Health, said: “Lockdowns have been a positive experience for many of our dogs, as they are social animals and love being with their owners.
“However, with the 2021 PFMA annual pet population report confirming that 3.2 million households in the UK have acquired a pet since the start of the pandemic, some pet owners have never left their dogs home alone, so it’s going to be a totally new experience which some pets may struggle with.
"Our new separation anxiety leaflet will help support both pets and owners as they adjust to the new normal.”
For further information, contact your local Ceva Animal Health account manager or email cevauk@ceva.com.
The company says the reason for the change is so that it can dedicate additional resources to the business.
Samantha Williamson, UK Country Manager at Animalcare, said: "Through our identichip microchips and our identibase pet database, we provide one of the UK’s longest-established pet microchipping services and are helping to reunite owners with their lost pets every single day.
"The pet reunification sector is evolving rapidly thanks to technological advances. We believe that the creation of identicare will facilitate the concentration of resources and expert knowledge needed to fuel the growth in our identichip business and continued enhancements to the identibase pet database. identicare will share the same passion and values as Animalcare and there will be no outward change for our customers.
“We look forward to continuing to deliver our ambition of delivering the highest quality pet reunification service under the identicare banner.”
The new company is part of the Animalcare Group.
The specialist-led lectures will start on 5th May and run until October 2021, with a session every couple of weeks, alternating between vets and nurses.
RCVS-recognised specialist in ECC, Tobias Grave, and Racheal Marshall RVN, head of clinical nursing at Vets Now, are among the speakers who will be covering topics such as damage control resuscitation, traumatic brain injury and neurotoxins. You can view the full programme here.
Dan Lewis, ECC specialist at Vets Now, who devised this year’s veterinary CPD programme, said: “Because emergencies don’t only happen out of hours we’re committed to working with general practitioners to deliver the best possible care to pets at the time they need it most. With that in mind, we are also committed to bringing relevant and pioneering CPD and training to veterinary clinicians and vet nurses.
“As emergency and critical care experts, we appreciate the value of flexibility and are always looking to adapt our services. In 2021, with social distancing still expected to be the norm, we’re offering two CPD streams, available live and on-demand.
“We delivered a successful interactive learning experience for virtual delegates through our ECC Congress at the end of last year, so we have a strong foundation from which to build on innovative and expert virtual CPD, and we’ll aim to leave delegates feeling well-informed and assured.
“We will obviously miss seeing everyone in person but gathering together online like this is beneficial as we can reach more vets and vet nurses with valuable CPD. Importantly, the format can fit around busy schedules, with all content available as videos after the events have taken place.”
Dan added: “Delegates from our ECC Congress commented on some added benefits of the virtual format including things like less environmental impact and waste through less travelling, and more flexibility due to being able to look back on the content after the event. Delegates also felt it was easier to ask questions of the speakers without feeling intimidated.”
The event series is priced at £72 for the vet stream (working out at £12 per session) and £60 for the vet nurse stream (£10 per session). You can also attend both for £110 (working out at £9.16 per session).
You can book your place at www.vets-now.com/bitesize.
The brainchild of Sonya Miles CertAVP(ZM), CertAqV, MRCVS, Just Exotic (www.justexotics.co.uk) offers a range of training webinars, fact sheets, care sheets and ‘how to’ videos developed for veterinary surgeons, nurses and students. The webinars cost between £15 and £55 (depending on the length), and include presentations by Sonya herself, Eliabetta Mancinelli, Agata Witkowska, Louise Ash, Sarah Pellett and others.
Sonya said: “We’ve developed our content to be convenient and affordable. Some of it may also be helpful for clients.
"More content will be added on a regular basis, and please, if there is something you specifically want covered, drop us a line to info@justexotics.co.uk and will we do our best to make sure it becomes available.”
The service is being led by Isuru Gajanayake, a board-certified specialist in veterinary nutrition. He said: “Since launching our clinical nutrition service last year, we have seen a number of cases in which patients have been either dehydrated or malnourished, sometimes both.
“Working alongside our other services in a truly multidisciplinary approach, we have been able to offer suitable treatment to support a significant number of dogs and cats.
“With the launch of the parenteral nutrition service, we can now expand this offering and, in doing so, become one of only a very few referral centres across the UK to provide this as a specialist service.
“Patients who are given parenteral nutrition will be hospitalised in our advanced intensive care unit to ensure they can be monitored closely by our specialist emergency and critical care (ECC) team, who provide exceptional expertise in critical care and treatment for every patient when they need it most.
Isuru added that the addition of the clinical nutrition and parenteral nutrition services at Willows ensures that there is a much greater emphasis on nutrition and hydration for all patients at the centre, whatever their underlying illness.
For more information, visit www.willows.uk.net or search for Willows Veterinary Centre and Referral Service on Facebook.
The course counts for four hours CPD, split into six short sessions which can be completed in your own time.
Presented by Dr Dan Cripwell BSc (Hons) BVSc CertAVP PgCert (VPS) MRCVS, Advanced Veterinary Practitioner and senior veterinary technical advisor at Jurox, the sessions consist of:
There is a quiz at the end of each module, following which, you can download a CPD certificate.
Suzy Ramsay, head of sales and marketing at Jurox (UK) Limited, said: “We are committed to developing unique and world class anaesthesia and analgesic products and practices within the animal health industry through the provision of up-to-date technical support and education. Our new Jurox Anaesthesia Academy CPD platform will enable veterinary professionals to adopt an evidence-based approach to their anaesthetic product choice and, in turn, help achieve the best possible anaesthetic outcomes for their patients.”
For access to the Jurox Anaesthesia Academy CPD platform, visit https://cpd.jurox.co.uk.
For further information, contact your local Jurox account manager, phone 0800 500 3171 or email customerservice@jurox.co.uk.
The company says that by encouraging socialisation, natural behaviour and good health practices, the campaign will help puppy owners get their journey off to a good start and, with their vet, raise a dog that is healthy and family friendly.
The initiative comprises a range of practice materials, including health advice, training and behaviour tips, and a new owner video covering the essentials of puppy ownership.
The materials include digital content to use in email campaigns and on practice websites and social media channels.
Further support on how to optimise social media channels is also available to practices through PetNatter – Boehringer's free veterinary resource designed to help practices make the most of the opportunities social media provides.
Evelyn Murphy, senior brand manager for NexGard Spectra, said: “The ‘Relax, it’s a Puppy Thing’ initiative is a breath of fresh air and will provide puppy owners with just what they need to help them nurture a puppy through its formative life-stage, while easily and effectively supporting practices in communicating with owners on puppy health and welfare.”
For further information, contact your Boehringer Ingelheim territory manager.
Alex is applying the data science he uses in his day job to help local vets at the Olive Ridley Project care for the ancient reptiles.
Six of the seven species of sea turtles are endangered due to human behaviour, many of them killed by poachers for their shells, eggs and meat.
They're also affected by the increasing volume of plastic waste in the sea.
Alex, who normally spends his time leading a team of business intelligence engineers and analysts who provide insights in finance, HR and clinical event reporting, is setting the charity up with practice management software to help it capture clinical records and track the sea turtles.
Alex said: "We’ll be setting up the software, making sure the vets can operate it and then adding all their existing data to it. We’re giving them a powerful tool to capture clinical records and manage turtles over a long period of time.”
“These valuable creatures are hugely important to marine ecosystems and have travelled our seas for the last 100 million years, so I’m delighted to be able to play a part in their conservation.”
For more information on the Olive Ridley Project, visit https://oliveridleyproject.org.
In the study titled 'Staphylococcal bacterial contamination of portable electronic devices in a large veterinary hospital1', samples were taken from the screen and any button of PEDs (such as mobile phones and tablets) of staff working directly with feline and canine patients. Hospital staff were asked to complete a questionnaire to ascertain the frequency of PED use and the frequency and method of PED cleaning.
The aim of the study was to determine the prevalence of Staphylococcal contamination of PEDs in a veterinary hospital, and to identify the source and determine the pathogenesis of any cultured strains.
Positive cultures were tested for resistance to oxacillin and vancomycin using a Kirby-Bauer disc diffusion test and then by using a broth microdilution test to EUCAST guidelines and breakpoints. PCR was used to specifically genotype the isolated staphylococci.
Georgia Vinall, corresponding author for the paper, said: “Useable swab samples were taken from 47 devices. Staphylococcus spp. were cultured from 68% of PEDs with a median of 10 colonies grown per device. Vancomycin-resistant Staphylococcus spp. were found on 36% of devices, whilst oxacillin-resistant Staphylococcus spp. were cultured from 2% of devices. DNA sequencing identified three Staphylococcus species; S. capitis, S. epidermidis and S. hominis which are most likely associated with humans as either sources or transmission vectors."
“The results of the survey indicate that 96% of staff had a PED which they used in the hospital environment, of which 85% use their device every day. Despite the high usage of PEDS in the hospital environment, only 6% of staff cleaned their device daily, with 33% of staff cleaning their PED less than weekly. Furthermore, only 54% of staff cleaned their device with a disinfectant."
Nicola Di Girolamo, Editor of JSAP said: "This study demonstrates that PEDs may become contaminated with potentially pathogenic microorganisms. Although this specific study did not focus on transmission of these microorganisms, and therefore it is unclear what are the clinical implications of this finding, it seems prudent to develop appropriate protocols for cleaning of PEDs in veterinary hospitals."
The full article can be found in the April issue of the Journal of Small Animal Practice and can be read online here: https://onlinelibrary.wiley.com/doi/10.1111/jsap.13289.
To nominate someone for inclusion in the showcase, visit: https://www.beva.org.uk/60-Faces
BEVA President Lucy Grieve said: "We are proud of BEVA’s heritage and want to recognise our 60th birthday by celebrating some of those who have made a significant difference to the equine veterinary community. We want you to help us identify the 60 individuals who you believe have truly inspired, influenced and progressed the equine veterinary profession for the better.”
Each of the nominated 60 faces will be highlighted on the website and on BEVA’s social media channels. Profile details will include career paths, workplaces and personal contributions to the equine veterinary profession.
Lucy added: "We have already started the list with Colonel John Hickman, Sue Dyson and Peter Rossdale. But there are hundreds of exceptional, deserving individuals who have made a huge difference to the equine veterinary profession and are worthy of our 60 Faces roll call."
The deadline for nominations is Friday 16th April 2021. All nominations are anonymous.
The company says that despite the development of alternatives to natural bone grafting, such as allografts and synthetic products, autologous bone graft is still considered the standard. However, it has a number of disadvantages, such as donor site morbidities and lameness, limited availability of graft volume (particularly in small size pets) and additional surgical time.
Biocera-Vet is a new bone substitute indicated in surgical procedures where bone grafting is necessary, such as arthrodesis, complex fractures, corrective osteotomy used in correction of limb deformities or as add-on to Tibial Tuberosity Advancement (TTA).
Biocera-Vet is an injectable synthetic self-hardening calcium-phosphate cement combining osteo-inductive, osteo-conductive and osteo-integrative properties designed to support a fast and strong consolidation.
TheraVet says Biocera-Vet also presents an excellent safety profile thanks to its biocompatibility, reduced comorbidities and superior ergonomics which save a significant amount of surgical time.
Dr Olivier Stiévenart, an orthopaedic veterinary surgeon at Surgivet in Belgium said: "Using Biocera-Vet has enabled us to optimise our patient care considerably, by reducing the operating time by at least 30 minutes. The use of an efficient and rapid bone substitute represents a real progress in terms of both operations and the animal’s quality of life".
Julie Schurgers, Chief Commercial Officer of TheraVet, said: "Biocera-Vet is a unique product on the veterinary bone substitute market, combining outstanding bone consolidation properties with an excellent safety profile and superior ergonomics. We are very excited today to announce its commercialisation on the market and are convinced that this innovative product will significantly improve the daily practices of veterinarians, for the well-being of patients and their owners."
The product is now available in Belgium, and will be rolled out in France and the Netherlands shortly, with the rest of Europe following later in 2021 / 2022.
For more information, visit: https://www.thera.vet/en/biocera-vet
Apovomin is effective after a single injection, with results in two to fifteen minutes.
Apovomin has the active substance apomorphine hydrochloride hemihydrate 3 mg (equivalent to apomorphine 2.56 mg). It is being marketed in 5 ml vials. It has a three-year shelf life and lasts for up to 28 days once broached.
Dechra Brand Manager Claire Morgan said: “Unfortunately there are many everyday substances that are toxic to dogs once ingested and time is of the essence when dogs have swallowed something that is poisonous to them.
“It is vital that veterinary professionals have access to a safe and effective treatment like Apovomin that they know they can rely on when dealing with cases like this.
“Apovomin offers a cost effective and successful treatment for accidental poisoning that will be an important tool for veterinary professionals in day-to-day practice.”
For more information visit www.dechra.co.uk.
In a statement issued this morning, the College explained that a review carried out after tea yesterday afternoon concluded that in the post pandemic world, most of its staff will continue to work from home. The need for office space is therefore limited to three meeting rooms and a kitchenette.
VetSurgeon.org understands that as a result, negotiations are already well advanced between the College and the owners of Ugland House in the Cayman Islands (pictured right) over the sale of one floor of the building, which is also home to 20,000 companies based on the tax-efficient island.
RCVS spokesperson Flora Olip said: “This move makes all sorts of sense. It represents a considerable cost-saving over our London premises and it puts the College at the very centre of the global veterinary community.
RCVS CEO Lizzie Lockett was last seen browsing the beachwear section of www.harrods.com.
The deal includes an option for the College to lease the building for up to two years to give it time to consider its options for the future, and how they may have changed as a result of the pandemic.
The decision to sell the property was made back in November 2018, when Council decided that the building was rapidly becoming unfit for purpose and the College needed more up-to-date and modern facilities with more room for a growing workforce. The College’s Estates Strategy Project Board was tasked with managing the process, chaired by former RCVS President Barry Johnson.
RCVS Treasurer Susan Dawson said: “Council recognised that this deal realised maximum value for the building, especially considering the impact the pandemic has had on property prices in Central London.
“It also provides a very valuable opportunity to reflect on the changing needs of the organisation and the professions and public it serves, and to consider the requirements and different working patterns of the College staff going forwards.
“It is likely that many staff members will wish to continue to work at home more than they did pre-Covid, so the need for pure desk-space may not be as great as we had planned for the 10-15 years ahead. However, the importance of in-person meetings for collaboration, creativity and the maintenance of good corporate culture is not to be underestimated, so our new requirements are likely to be different to that anticipated back in 2018.”
The College says it expects to welcome limited numbers of staff back to the office in June, to work in a socially distanced way, including virtual or partly-virtual meetings.
Changes to working patterns over the coming months will also help inform decisions around future remote working policies and the type and size of building that will best suit the future needs of the College and its workforce.
The new course is called ‘New staff training course with Post2Pet’, and, as the name suggests, it will look at how to incorporate the home delivery option into a preventative healthcare plan.
Premier Vet Alliance says the course is suitable for any member of the practice team that wants to increase their knowledge about healthcare plans.
The course is 4 modules long with an assessment leading to 1.5 hours of completed CPD. It will launch towards the end of April.
James Tudor, Head of Customer Experience at Premier Vet Alliance, said: "This is a fantastic resource and I am I so proud of the team who’ve developed this and helped practices to train staff efficiently and effectively.
"It’s opening up the future of training and we hope to gain guidance in developing our training provision by working directly with practices, to help keep the training relevant.
"We see real value in CPD accredited courses, especially where they help enable veterinary staff to increase their knowledge on maximising their clients’ compliance. They can also learn how to influence animal health, and drive other aspects of the business through health plans."
"This is just the beginning; we will continue to increase our CPD accreditations and share best practice across Europe and the United States."
For more information contact 0117 370 0300 or email pcp@premiervetalliance.co.uk .
201 practices took part in the survey between 25th February and 4th March 2021. The main findings were:
Lizzie Lockett, RCVS CEO, said: “Although this survey took place in the midst of the lockdown and before the schools re-opened, there were some positive results here around staffing and the financial situation for practices. Hopefully this will mean that, as the restrictions ease going from spring into summer, many practices and practice staff will be in a position to return to a near-normal level of service and business.
"There were, however, still a few areas of concern, some of which will hopefully be resolved by the forthcoming easing of restrictions, for example, the difficulty in obtaining independent witnesses for the destruction of controlled drugs, with some 34% of practices reporting difficulties, compared to 20% in December.
“Once again, I would like to thank all those practices who responded to this and previous surveys, and continue to provide invaluable evidence and feedback about the current state of veterinary practice.”
The full results of the survey can be downloaded at: www.rcvs.org.uk/publications
Cryptisel is for use in reducing oocyst shedding in calves where diarrhoea caused by Cryptosporidium is a problem. After the presence of the causal organism has been established, Forte says Cryptisel can be used in all new-born calves to break the cycle of transmission and multiplication on-farm.
Dr John Henderson, Large Animal Product Manager with Forte Healthcare Ltd said: "Cryptisel will be a very useful medicine in the control of the most commonly-identified scour pathogen in the UK and Ireland. Used alongside the calf-rearing cornerstones of good colostrum management, hygiene, and biosecurity, Cryptisel will reduce production of Cryptosporidium oocysts and help limit spread of the disease among susceptible calves."
Cryptisel is a POM, available in 490ml and 980ml bottles. Both sizes come with a metered dosing pump for convenient administration.
For further information, contact your local Forte Territory Manager or email enquiries@fortehealthcare.com.